Forbion follows €2bn double fundraise with above-target BioEconomy I fund close

Life sciences-focused venture capital major Forbion has beaten its goal for debut BioEconomy Fund, which will target B2B solutions that replace unsustainable products with scalable, cost-effective alternatives.